# Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, Division 2.1.1

Extent: E+W+S+N.I.

Salicylanilides
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Closantel
Closantel
Bovine
1 000 μg/kg
Muscle
3 000 μg/kg
Fat
1 000 μg/kg
Liver
3 000 μg/kg
Kidney
Ovine
1 500 μg/kg
Muscle
2 000 μg/kg
Fat
1 500 μg/kg
Liver
5 000 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/1999/508/annex/I/division/2/division/2.1/division/2.1.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-1999-508/annex-I/division-2/division-2.1/division-2.1.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.